15-41841265-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001114633.2(PLA2G4B):c.427G>A(p.Val143Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000311 in 1,612,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001114633.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLA2G4B | NM_001114633.2 | c.427G>A | p.Val143Ile | missense_variant | 6/20 | ENST00000458483.4 | |
JMJD7-PLA2G4B | NM_005090.4 | c.1120G>A | p.Val374Ile | missense_variant | 11/25 | ||
JMJD7-PLA2G4B | NM_001198588.2 | c.1120G>A | p.Val374Ile | missense_variant | 11/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLA2G4B | ENST00000458483.4 | c.427G>A | p.Val143Ile | missense_variant | 6/20 | 2 | NM_001114633.2 | P1 | |
PLA2G4B | ENST00000452633.5 | c.427G>A | p.Val143Ile | missense_variant | 7/21 | 5 | P1 | ||
PLA2G4B | ENST00000461382.5 | n.528G>A | non_coding_transcript_exon_variant | 6/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000173 AC: 43AN: 248388Hom.: 0 AF XY: 0.000171 AC XY: 23AN XY: 134558
GnomAD4 exome AF: 0.000309 AC: 452AN: 1460648Hom.: 0 Cov.: 35 AF XY: 0.000283 AC XY: 206AN XY: 726676
GnomAD4 genome AF: 0.000328 AC: 50AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74454
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at